HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Analysts at Northland Securities boosted their Q3 2027 earnings estimates for shares of HIVE Blockchain Technologies in a report issued on Tuesday, November 10th. Northland Securities analyst M. Grondahl now expects that the company will earn ($0.18) per share for the quarter, up from their previous estimate of ($0.19). Northland Securities also issued estimates for HIVE Blockchain Technologies’ Q4 2027 earnings at ($0.13) EPS.
Separately, Chardan Capital raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Monday, July 27th. Two equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy”.
Get Our Latest Stock Report on HIVE Blockchain Technologies
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
Featured Articles
- Five stocks we like better than HIVE Blockchain Technologies
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
